Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient-Reference-Cited by-同舟云学术

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Published:2003-12 Issue:6 Volume:39 Page:1085-1089
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Villeneuve Jean-Pierre,Durantel David,Durantel Sandra,Westland Christopher,Xiong Shelly,Brosgart Carol L,Gibbs Craig S,Parvaz Parviz,Werle Bettina,Trépo Christian,Zoulim Fabien

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. Lamivudine as initial treatment for chronic hepatitis B in the United States;Dienstag;N Engl J Med,1999

2. A 1 year trial of lamivudine for chronic hepatitis B;Lai;N Engl J Med,1998

3. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy;Leung;Hepatology,2001

4. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group [see comments];Liaw;Gastroenterology,2000

5. A preliminary benefit-risk assessment of Lamivudine for the treatment of chronic hepatitis B virus infection;Zoulim;Drug Saf,2002

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, clinical and virological characteristics and short‐term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania;Journal of Viral Hepatitis;2024-05-21

2. Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants;Scientific Reports;2022-06-17

3. A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype;Journal of Viral Hepatitis;2022-06-07

4. Traitement de l’hépatite B chronique par ténofovir : aspects virologiques et pharmacologiques;Virologie;2022-05-01

5. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study;The Lancet Global Health;2022-04